Skip to main content

Advertisement

SpringerLink
Log in

Obesity Education Strategies for Cancer Prevention in Women’s Health

  • Gynecologic Oncology (R Salani, Section Editor)
  • Published:
Current Obstetrics and Gynecology Reports Aims and scope Submit manuscript

Abstract

Obesity is the cause of up to one third of all cancers affecting women today, most notably endometrial, colon, and breast cancers. Women’s health providers are poised to advise women on obesity’s link to cancer development, but often lack resources or training to provide appropriate counseling. Here, we review obesity’s role in increasing the risk of several common reproductive system conditions faced by women, including polycystic ovarian syndrome, infertility, gynecologic surgical complications, and pregnancy complications. These events can be used as teachable moments to help frame the discussion of weight management and promote cancer prevention. We also review national guidelines and existing tangible weight-loss strategies that can be employed within the outpatient women’s health setting to help women achieve weight-loss goals and affect cancer prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Flegal KM, Graubard BI. Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr. 2009;89(4):1213–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Calle EE et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38.

    Article  PubMed  Google Scholar 

  3. Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15(6):556–65.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Ligibel JA et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32(31):3568–74. The ASCO statement on obesity management underscores the need for oncologists to address patients’ weight and facilitate weight management.

    Article  PubMed  Google Scholar 

  5. ACOG Committee Opinion No. 600: Ethical issues in the care of the obese woman. Obstet Gynecol. 2014;123(6):1388–93. The ACOG committee opinion underscores that despite the difficulty of caring for women with obesity, we as women’s health providers are obligated to care for them and address issues most pertinent to their overall health.

  6. U.S. Department of Health and Human Services. Three steps to initiate discussion about weight management. National Institutes of Health National Heart, Lung, and Blood Institute; 2002. NIHPub ID: 02-5211.

  7. Farquhar CM et al. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am J Obstet Gynecol. 1999;181(3):525–9.

    Article  CAS  PubMed  Google Scholar 

  8. Rose PG. Endometrial carcinoma. N Engl J Med. 1996;335(9):640–9.

    Article  CAS  PubMed  Google Scholar 

  9. MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol. 1974;2(2-3):122–9.

    Article  CAS  PubMed  Google Scholar 

  10. Heller DS et al. Body mass index of patients with endometrial hyperplasia: comparison to patients with proliferative endometrium and abnormal bleeding. J Reprod Med. 2011;56(3-4):110–2.

    PubMed  Google Scholar 

  11. Smithling KR et al. Preoperative uterine bleeding pattern and risk of endometrial ablation failure. Am J Obstet Gynecol. 2014;211(5):556 e1-6.

    Article  PubMed  Google Scholar 

  12. Pare E et al. Clinical risk factors for preeclampsia in the 21st century. Obstet Gynecol. 2014;124(4):763–70.

    Article  CAS  PubMed  Google Scholar 

  13. Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013;71 Suppl 1:S18–25.

    Article  PubMed  Google Scholar 

  14. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Bilano VL et al. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One. 2014;9(3), e91198.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med. 1999;341(23):1749–56.

    Article  CAS  PubMed  Google Scholar 

  17. Jovanovic L, Pettitt DJ. Gestational diabetes mellitus. JAMA. 2001;286(20):2516–8.

    Article  CAS  PubMed  Google Scholar 

  18. Phelan S. Pregnancy: a “teachable moment” for weight control and obesity prevention. Am J Obstet Gynecol. 2010;202(2):135 e1-8.

    Article  PubMed  Google Scholar 

  19. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030.

    Article  CAS  PubMed  Google Scholar 

  20. Jayasena CN, Franks S. The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol. 2014;10(10):624–36.

    Article  PubMed  Google Scholar 

  21. Herber-Gast GC et al. Risk factors for night sweats and hot flushes in midlife: results from a prospective cohort study. Menopause. 2013;20(9):953–9.

    Article  PubMed  Google Scholar 

  22. Whiteman MK et al. Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol. 2003;101(2):264–72.

    Article  PubMed  Google Scholar 

  23. Thurston RC et al. Abdominal adiposity and hot flashes among midlife women. Menopause. 2008;15(3):429–34.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Huang AJ et al. An intensive behavioral weight loss intervention and hot flushes in women. Arch Intern Med. 2010;170(13):1161–7.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Giugale LE et al. Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia. Gynecol Oncol. 2012;127(2):326–31.

    Article  PubMed  Google Scholar 

  26. Siedhoff MT et al. Effect of extreme obesity on outcomes in laparoscopic hysterectomy. J Minim Invasive Gynecol. 2012;19(6):701–7.

    Article  PubMed  Google Scholar 

  27. Morgan-Ortiz F et al. Effect of body mass index on clinical outcomes of patients undergoing total laparoscopic hysterectomy. Int J Gynaecol Obstet. 2013;120(1):61–4.

    Article  PubMed  Google Scholar 

  28. Mikhail E et al. Association between obesity and the trends of routes of hysterectomy performed for benign indications. Obstet Gynecol. 2015;125(4):912–8.

    Article  PubMed  Google Scholar 

  29. Burgio KL et al. Urinary incontinence in the 12-month postpartum period. Obstet Gynecol. 2003;102(6):1291–8.

    Article  PubMed  Google Scholar 

  30. Brown JS et al. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol. 1999;94(1):66–70.

    Article  CAS  PubMed  Google Scholar 

  31. Cummings JM, Rodning CB. Urinary stress incontinence among obese women: review of pathophysiology therapy. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(1):41–4.

    Article  CAS  PubMed  Google Scholar 

  32. Hannestad YS et al. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG. 2003;110(3):247–54.

    Article  PubMed  Google Scholar 

  33. Richter HE et al. Factors associated with incontinence frequency in a surgical cohort of stress incontinent women. Am J Obstet Gynecol. 2005;193(6):2088–93.

    Article  PubMed  Google Scholar 

  34. Miedel A et al. Nonobstetric risk factors for symptomatic pelvic organ prolapse. Obstet Gynecol. 2009;113(5):1089–97.

    Article  PubMed  Google Scholar 

  35. Kudish BI et al. Effect of weight change on natural history of pelvic organ prolapse. Obstet Gynecol. 2009;113(1):81–8.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Bradley CS et al. Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol. 2007;109(4):848–54.

    Article  PubMed  Google Scholar 

  37. Bianchini F, Kaaks R, Vainio H. Weight control and physical activity in cancer prevention. Obes Rev. 2002;3(1):5–8.

    Article  PubMed  Google Scholar 

  38. Kushi LH et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1):30–67. The ACS guidelines on nutrition and physical activity provide an excellent opportunity for discussion in an office visit. Studies have shown that even minimal support and encouragement from physcians can help to facilitate change and prompt weight loss and behavioral change.

    Article  PubMed  Google Scholar 

  39. Martin PD et al. Weight loss maintenance following a primary care intervention for low-income minority women. Obesity (Silver Spring). 2008;16(11):2462–7.

    Article  Google Scholar 

  40. Tsai AG et al. A primary care intervention for weight loss: results of a randomized controlled pilot study. Obesity (Silver Spring). 2010;18(8):1614–8.

    Article  Google Scholar 

  41. Wadden TA et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med. 2011;365(21):1969–79.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Ockene IS et al. Effect of physician-delivered nutrition counseling training and an office-support program on saturated fat intake, weight, and serum lipid measurements in a hyperlipidemic population: Worcester Area Trial for Counseling in Hyperlipidemia (WATCH). Arch Intern Med. 1999;159(7):725–31.

    Article  CAS  PubMed  Google Scholar 

  43. Power ML, Cogswell ME, Schulkin J. Obesity prevention and treatment practices of U.S. obstetrician-gynecologists. Obstet Gynecol. 2006;108(4):961–8.

    Article  PubMed  Google Scholar 

  44. Kuroki LM et al. Awareness of the association between obesity and peri-operative risk among newly diagnosed patients with complex atypical hyperplasia and endometrial cancer. Gynecol Oncol Rep. 2015;12:41–4.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Neff R et al. Is bariatric surgery an option for women with gynecologic cancer? Examining weight loss counseling practices and training among gynecologic oncology providers. Gynecol Oncol. 2014;134(3):540–5.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Williams LT et al. Can a relatively low-intensity intervention by health professionals prevent weight gain in mid-age women? 12-Month outcomes of the 40-Something randomised controlled trial. Nutr Diabetes. 2014;4, e116.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. Nawaz H, Adams ML, Katz DL. Weight loss counseling by health care providers. Am J Public Health. 1999;89(5):764–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. Hollis JF et al. Weight loss during the intensive intervention phase of the weight-loss maintenance trial. Am J Prev Med. 2008;35(2):118–26.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Smith LP, Ng SW, Popkin BM. Trends in US home food preparation and consumption: analysis of national nutrition surveys and time use studies from 1965-1966 to 2007-2008. Nutr J. 2013;12:45.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Chen L et al. Reduction in consumption of sugar-sweetened beverages is associated with weight loss: the PREMIER trial. Am J Clin Nutr. 2009;89(5):1299–306.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. McCullough ML et al. Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol Biomarkers Prev. 2011;20(6):1089–97.

    Article  PubMed  Google Scholar 

  52. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6 Suppl 2:51S–209.

    Google Scholar 

  53. Bennett GG et al. Pedometer-determined physical activity among multiethnic low-income housing residents. Med Sci Sports Exerc. 2006;38(4):768–73.

    Article  PubMed Central  PubMed  Google Scholar 

  54. Yang L, Colditz GA. An active lifestyle for cancer prevention. J Natl Cancer Inst. 2014;106(7). doi:10.1093/jnci/dju135.

  55. Patel AV et al. Leisure-time spent sitting and site-specific cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev. 2015;24(9):1350–9.

    Article  PubMed  Google Scholar 

  56. Hu FB et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003;289(14):1785–91.

    Article  PubMed  Google Scholar 

  57. Thelwall S, Harrington P, Sheridan E, Lamagni T. Impact of obesity on the risk of wound infection following surgery: results from a nationwide prospective multicentre cohort study in England. Clin Microbiol Infect. 2015. doi:10.1016/j.cmi.2015.07.003.

  58. Hebert JR et al. A dietitian-delivered group nutrition program leads to reductions in dietary fat, serum cholesterol, and body weight: the Worcester Area Trial for Counseling in Hyperlipidemia (WATCH). J Am Diet Assoc. 1999;99(5):544–52.

    Article  CAS  PubMed  Google Scholar 

  59. Hutchesson MJ et al. Changes to dietary intake during a 12-week commercial web-based weight loss program: a randomized controlled trial. Eur J Clin Nutr. 2014;68(1):64–70.

    Article  CAS  PubMed  Google Scholar 

  60. Tol J et al. Dietetic treatment lowers body mass index in overweight patients: an observational study in primary health care. J Hum Nutr Diet. 2014;27(5):426–33.

    Article  CAS  PubMed  Google Scholar 

  61. Donini LM et al. Obesity treatment: results after 4 years of a Nutritional and Psycho-Physical Rehabilitation Program in an outpatient setting. Eat Weight Disord. 2014;19(2):249–60.

    Article  PubMed  Google Scholar 

  62. Funk KL et al. Associations of internet website use with weight change in a long-term weight loss maintenance program. J Med Internet Res. 2010;12(3), e29.

    Article  PubMed Central  PubMed  Google Scholar 

  63. Vojta D et al. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program. Am J Prev Med. 2013;44(4 Suppl 4):S301–6.

    Article  PubMed  Google Scholar 

  64. Gudzune KA et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015;162(7):501–12.

    Article  PubMed  Google Scholar 

  65. Dansinger ML et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293(1):43–53.

    Article  CAS  PubMed  Google Scholar 

  66. Gardner CD et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 2007;297(9):969–77.

    Article  CAS  PubMed  Google Scholar 

  67. Alhassan S et al. Dietary adherence and weight loss success among overweight women: results from the A TO Z weight loss study. Int J Obes (Lond). 2008;32(6):985–91.

    Article  CAS  Google Scholar 

  68. Hiatt WR, Thomas A, Goldfine AB. What cost weight loss? Circulation. 2012;125(9):1171–7.

    Article  PubMed  Google Scholar 

  69. Manning S, Pucci A, Finer N. Pharmacotherapy for obesity: novel agents and paradigms. Ther Adv Chronic Dis. 2014;5(3):135–48.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  70. Torgerson JS et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27(1):155–61.

    Article  CAS  PubMed  Google Scholar 

  71. Smith SR et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363(3):245–56.

    Article  CAS  PubMed  Google Scholar 

  72. Fidler MC et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab. 2011;96(10):3067–77.

    Article  CAS  PubMed  Google Scholar 

  73. Rueda-Clausen CF, Padwal RS, Sharma AM. New pharmacological approaches for obesity management. Nat Rev Endocrinol. 2013;9(8):467–78.

    Article  CAS  PubMed  Google Scholar 

  74. Gadde KM et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377(9774):1341–52.

    Article  CAS  PubMed  Google Scholar 

  75. Garvey WT et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95(2):297–308.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  76. Allison DB et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012;20(2):330–42.

    Article  CAS  Google Scholar 

  77. Astrup A et al. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond). 2012;36(6):843–54.

    Article  CAS  Google Scholar 

  78. Astrup A et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet. 2009;374(9701):1606–16.

    Article  CAS  PubMed  Google Scholar 

  79. Greenway FL et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595–605.

    Article  CAS  PubMed  Google Scholar 

  80. Pi-Sunyer X et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11–22.

    Article  PubMed  Google Scholar 

  81. Berne C, Orlistat Swedish G. Type 2 diabetes study, a randomized study of orlistat in combination with a weight management programme in obese patients with type 2 diabetes treated with metformin. Diabet Med. 2005;22(5):612–8.

    Article  CAS  PubMed  Google Scholar 

  82. Jacob S et al. Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss. Diabetes Obes Metab. 2009;11(4):361–71.

    Article  CAS  PubMed  Google Scholar 

  83. O’Neil PM et al. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring). 2012;20(7):1426–36.

    Article  Google Scholar 

  84. Hollander P et al. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. 2013;36(12):4022–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  85. Van Gaal L, Scheen A. Weight management in type 2 diabetes: current and emerging approaches to treatment. Diabetes Care. 2015;38(6):1161–72.

    Article  PubMed  Google Scholar 

  86. Sjostrom L et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653–62.

    Article  PubMed  Google Scholar 

  87. Adams TD et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.

    Article  CAS  PubMed  Google Scholar 

  88. Schauer PR, Bhatt DL, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med. 2014;371(7):682.

    CAS  PubMed  Google Scholar 

  89. Sjostrom L et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.

    Article  PubMed  Google Scholar 

  90. Sjostrom L et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.

    Article  PubMed  Google Scholar 

  91. Sjostrom L et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.

    Article  PubMed  Google Scholar 

  92. Sjostrom L et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.

    Article  PubMed  Google Scholar 

  93. Kashyap SR et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013;36(8):2175–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  94. Courcoulas AP et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416–25.

    PubMed Central  CAS  PubMed  Google Scholar 

  95. Lindekilde N et al. The impact of bariatric surgery on quality of life: a systematic review and meta-analysis. Obes Rev. 2015;16(8):639–51.

    Article  CAS  PubMed  Google Scholar 

  96. Mechanick JI et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013;21 Suppl 1:S1–27.

    Article  CAS  Google Scholar 

  97. Nguyen NT et al. Trends in use of bariatric surgery, 2003-2008. J Am Coll Surg. 2011;213(2):261–6.

    Article  PubMed  Google Scholar 

  98. Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond). 2013;37(6):889–91.

    Article  CAS  Google Scholar 

  99. Funk LM, Jolles S, Fischer LE, Voils CI. Patient and referring practitioner characteristics associated with the likelihood of undergoing bariatric surgery: a systematic review. JAMA Surg. 2015. doi:10.1001/jamasurg.2015.1250.

  100. Jernigan AM, Tergas AI, Satin AJ, Fader AN. Obesity management in gynecologic cancer survivors: provider practices and attitudes. Am J Obstet Gynecol. 2015;208(5):408.e1–8. doi:10.1016/j.ajog.2013.02.002.

  101. Atwood K, Colditz GA, Kawachi I. From public health science to prevention policy: placing science in its social and political contexts. Am J Public Health. 1997;87(10):1603–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Compliance with Ethical Standards

ᅟ

Conflict of Interest

Lucy Liu, Abraham Segura, and Andrea R. Hagemann declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Washington University School of Medicine, 4911 Barnes-Jewish Hospital Plaza, Campus Box 8064, St. Louis, MO, 63110, USA

    Lucy Liu & Andrea R. Hagemann

  2. Washington University School of Medicine, 660 S. Euclid Avenue, St. Louis, MO, 63110, USA

    Abraham Segura

Authors
  1. Lucy Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abraham Segura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea R. Hagemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea R. Hagemann.

Additional information

This article is part of the Topical Collection on Gynecologic Oncology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, L., Segura, A. & Hagemann, A.R. Obesity Education Strategies for Cancer Prevention in Women’s Health. Curr Obstet Gynecol Rep 4, 249–258 (2015). https://doi.org/10.1007/s13669-015-0129-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13669-015-0129-8

Keywords

Search

Navigation